Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy

MLA

Douglas B. Evans, et al. “Survival of Patients with Resectable Pancreatic Cancer Who Received Neoadjuvant Therapy.” Surgery, vol. 159, Mar. 2016, pp. 893–900. EBSCOhost, https://doi.org/10.1016/j.surg.2015.09.018.

APA

Douglas B. Evans, Fabian M. Johnston, Susan Tsai, Jonathan W. Heimler, Parag Tolat, Paul S. Ritch, W D Foley, Beth Erickson, Kathleen K. Christians, & Ben George. (2016). Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. Surgery, 159, 893–900. https://doi.org/10.1016/j.surg.2015.09.018

Chicago

Douglas B. Evans, Fabian M. Johnston, Susan Tsai, Jonathan W. Heimler, Parag Tolat, Paul S. Ritch, W D Foley, Beth Erickson, Kathleen K. Christians, and Ben George. 2016. “Survival of Patients with Resectable Pancreatic Cancer Who Received Neoadjuvant Therapy.” Surgery 159 (March): 893–900. doi:10.1016/j.surg.2015.09.018.